1-(2-Trifluoromethyl-phenyl)-piperidine-4-carboxylic acid, 95.0%, 1g

3-chloro-5-methoxy-1-methyl-1H-1,2,4-triazole, 95.0%, 10g

E-Plan phase EPLPHi S100x/1.25 oil immersion infinity corrected IOS objective. Working distance 0.36 mm

Ru(OAc)2[(S)-xylbinap]200mg

(S)-tert-butyl 2-(5-(4-chlorophenyl)-6,7-dimethyl-2-oxo-2,3-dihydro-1H-thieno[2,3-e][1,4]diazepin-3-yl)acetate, 98%, 50mg

3-Fluoro-2-trifluoromethylpyridine, 98.0%, 1g

(4-Iodo-3-methylphenyl)methanol, 98%, 1g

3-iodo-2H-indazole-6-carboxylic acid, 97%, 1g

1H-Pyrrolo[3,2-b]pyridine-7-carboxylic acid, 95.0%, 1g

[1,1'-Biphenyl]-2,2'-diyldiboronic acid, 95.0%, 250mg

2,5-Dibromo-4-methylpyrimidine, 95.0%, 10g

Silicagel 60A 40-63u, 1kg

1-Methoxy-4-(propylthio)-benzene, 25g